Optimization of human T-cell expansion ex vivo using magnetic beads conjugated with anti-CD3 and Anti-CD28 antibodies
about
T cell receptor-transgenic primary T cells as a tool for discovery of leukaemia-associated antigens.A global transcriptional view of apoptosis in human T-cell activation.Comparison of polyclonal expansion methods to improve the recovery of cervical cytobrush-derived T cells from the female genital tract of HIV-infected womenIntramuscular therapeutic vaccination targeting HPV16 induces T cell responses that localize in mucosal lesions.Principles of adoptive T cell cancer therapy.Inclusion of Strep-tag II in design of antigen receptors for T-cell immunotherapy.Generation of tumor-specific T lymphocytes using dendritic cell/tumor fusions and anti-CD3/CD28CMVpp65 Vaccine Enhances the Antitumor Efficacy of Adoptively Transferred CD19-Redirected CMV-Specific T Cells.T-cell reconstitution and expansion after hematopoietic stem cell transplantation: 'T' it up!Bidirectional coupling between ryanodine receptors and Ca2+ release-activated Ca2+ (CRAC) channel machinery sustains store-operated Ca2+ entry in human T lymphocytes.Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation.Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull mice.Costimulation with anti-cluster of differentiation 3 and anti-cluster of differentiation 28 reduces the activity of mucin 1-stimulated human mononuclear cells.Manufacturing validation of biologically functional T cells targeted to CD19 antigen for autologous adoptive cell therapy.Post-transplant adoptive T-cell immunotherapy.Monoclonal antibody-induced cytokine-release syndrome.Biomarkers in T cell therapy clinical trials.Fusions of dendritic cells with breast carcinoma stimulate the expansion of regulatory T cells while concomitant exposure to IL-12, CpG oligodeoxynucleotides, and anti-CD3/CD28 promotes the expansion of activated tumor reactive cells.Shifting paradigms in the treatment of chronic lymphocytic leukemia.Retroviral insertional mutagenesis can contribute to immortalization of mature T lymphocytes.Development of genetically engineered CD4+ and CD8+ T cells expressing TCRs specific for a M. tuberculosis 38-kDa antigen.In vitro activation of cytotoxic T-lymphocytes by hTERT-pulsed dendritic cells.Intact CD100-CD72 Interaction Necessary for TCR-Induced T Cell Proliferation.Pleiotrophin produced by multiple myeloma induces transdifferentiation of monocytes into vascular endothelial cells: a novel mechanism of tumor-induced vasculogenesis.Efficacy of Adoptive T-cell Therapy Is Improved by Treatment with the Antioxidant N-Acetyl Cysteine, Which Limits Activation-Induced T-cell Death.Fine tuning and efficient T cell activation with stimulatory aCD3 nanoarrays.A reproducible method for the expansion of mouse CD8+ T lymphocytes.Generation of autologous tumor-specific T cells for adoptive transfer based on vaccination, in vitro restimulation and CD3/CD28 dynabead-induced T cell expansion.In vitro stimulation and expansion of human tumour-reactive CD8+ cytotoxic T lymphocytes by anti-CD3/CD28/CD137 magnetic beads.Polyclonal expansion of cervical cytobrush-derived T cells to investigate HIV-specific responses in the female genital tract.Optimization of in vitro expansion of macaque CD4 T cells using anti-CD3 and co-stimulation for autotransfusion therapy.N-acetyl-L-cysteine increases acute graft-versus-host disease and promotes T-cell-mediated immunity in vitro.Anti-inflammatory effects of Artemisia princeps in antigen-stimulated T cells and regulatory T cells.Cationic polymers for non-viral gene delivery to human T cells.
P2860
Q33230010-802CC9A6-E069-4CA3-8549-14D7D9DD87AFQ33378974-FC4AA66D-FA1E-4AC5-9D1B-46762EE77C58Q33790476-D9D49FEF-D8B4-4E59-9A5B-C1AA912A4073Q33862762-B6542A43-B57A-4A1E-9E59-7661EA5E3936Q34003932-A9359BA8-F5A3-49B1-BEFA-E7D8BFCDA712Q34046252-3B7CD0A0-3F35-41D7-8F4F-97C1E9494FF8Q34122445-6DCA1ABC-BCCB-4931-8788-91407952C9B9Q35811921-277347FC-AC97-4FD7-99BF-E829537E08ABQ36087036-2ADE9B53-7179-4974-999D-5ADE3D5DAA7CQ36347809-4C24BB96-D003-459F-98CF-6C5299F892F6Q36407079-719F4890-02E5-46C4-B53A-2298F30CB1B4Q36453843-9C81372D-96F5-4604-AC2F-6106CF0E9971Q36519394-9984FFAB-6E5B-40BB-B56B-BC6C3D695649Q37196769-B7BD9592-CC9C-48B1-91AE-F7E3B5CD345BQ37268318-264492C7-A353-4033-B28E-C148FDDD9288Q37755276-3D0A5BE5-51FA-4BDD-8453-E0A10FA6729EQ37919589-E768B1BE-AAF9-429D-B00F-065938935991Q38289899-09BB37CF-A648-4B6C-94EA-2306ECBB0936Q38357127-113AF95A-E0B3-4B0A-8FBC-DAFA0427C8DBQ39493084-5B0EF05A-E562-403B-9A2D-CA1CB6959701Q39752168-887214F4-7938-4773-813D-6F0895A47DC7Q39775722-BD18CB3D-3A2A-49C4-A803-BAF5C40EE775Q40132785-348E96DD-3D71-4AD0-A053-60BF502D3166Q41970491-FFE9D384-94E1-4FDA-8B35-284D2E75F934Q42381105-A0802919-73EF-4368-90CB-1D43C981C742Q42876926-61FF1129-3793-4FBB-921D-84C2AED2541DQ43179806-6F511130-2DA7-48DB-B95A-AA7EE73E2D92Q50973652-73ED7FD4-B93A-4C47-9140-AE721EADCFB3Q51011471-34E61981-6F43-469E-92C9-BADE15F11E61Q51579688-7083DF08-44F6-4517-9579-5EE5C9B53BF0Q51980648-12A7B148-4336-49FD-AEB0-E25DD96534B5Q53266395-163790DA-A9B8-4473-8EC4-7A48810CB05BQ53498925-EC779A19-950B-4360-A4E9-30E23D8A3954Q54259697-00F3E73A-3F84-42A4-A24C-F45B605FC233
P2860
Optimization of human T-cell expansion ex vivo using magnetic beads conjugated with anti-CD3 and Anti-CD28 antibodies
description
2004 nî lūn-bûn
@nan
2004 թուականին հրատարակուած գիտական յօդուած
@hyw
2004 թվականին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Optimization of human T-cell e ...... i-CD3 and Anti-CD28 antibodies
@ast
Optimization of human T-cell e ...... i-CD3 and Anti-CD28 antibodies
@en
Optimization of human T-cell e ...... i-CD3 and Anti-CD28 antibodies
@nl
type
label
Optimization of human T-cell e ...... i-CD3 and Anti-CD28 antibodies
@ast
Optimization of human T-cell e ...... i-CD3 and Anti-CD28 antibodies
@en
Optimization of human T-cell e ...... i-CD3 and Anti-CD28 antibodies
@nl
prefLabel
Optimization of human T-cell e ...... i-CD3 and Anti-CD28 antibodies
@ast
Optimization of human T-cell e ...... i-CD3 and Anti-CD28 antibodies
@en
Optimization of human T-cell e ...... i-CD3 and Anti-CD28 antibodies
@nl
P2093
P1476
Optimization of human T-cell e ...... i-CD3 and Anti-CD28 antibodies
@en
P2093
Dale Kalamasz
Jane H Buckner
Mark Bonyhadi
Ronald J Berenson
Ruth Taniguchi
P304
P356
10.1097/00002371-200409000-00010
P407
P577
2004-01-01T00:00:00Z